Cedarburg Hauser Adds Controlled Substance Capabilities at Denver Site

Cedarburg Hauser Pharmaceuticals has announced the addition of controlled substance capabilities at its Denver, CO facility. Both of Cedarburg Hauser's facilities, in Colorado and Wisconsin, now hold DEA registrations allowing for the production and analysis of schedule II-V controlled substances.

The kilo-lab manufacturing suites and analytical laboratories at the Denver location are ideal for the development of small molecule APIs, particularly those with unique manufacturing challenges such as potent compounds, controlled substances, and small molecule conjugates.

Cedarburg Hauser specializes in the development and manufacturing of small molecule APIs. We leverage a talented group of scientists and supporting-staff, as well as a centralized approach to project management, to ensure on-time and on-budget completion of projects involving the development, scale-up, and manufacturing of complex APIs.

 

Company

Cedarburg Hauser Pharmaceuticals

870 Badger Circle
WI 53024 Grafton

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.